RÉSUMÉ
Shortening of airway smooth muscle and bronchoconstriction are pathognomonic for asthma. Airway shortening occurs through calcium-dependent activation of myosin light chain kinase, and RhoA-dependent calcium sensitization, which inhibits myosin light chain phosphatase. The mechanism through which pro-contractile stimuli activate calcium sensitization is poorly understood. Our review of the literature suggests that pro-contractile G protein coupled receptors likely signal through G12/13 to activate RhoA and mediate calcium sensitization. This hypothesis is consistent with the effects of pro-contractile agonists on RhoA and Rho kinase activation, actin polymerization and myosin light chain phosphorylation. Recognizing the likely role of G12/13 signaling in the pathophysiology of asthma rationalizes the effects of pro-contractile stimuli on airway hyperresponsiveness, immune activation and airway remodeling, and suggests new approaches for asthma treatment.
Sujet(s)
Asthme , Transduction du signal , Asthme/métabolisme , Asthme/physiopathologie , Asthme/traitement médicamenteux , Humains , Transduction du signal/physiologie , Animaux , Sous-unités alpha G12-G13 des protéines G/métabolisme , Muscles lisses/métabolisme , Muscles lisses/physiopathologie , Muscles lisses/effets des médicaments et des substances chimiques , Remodelage des voies aériennes/physiologieRÉSUMÉ
Disorders of gallbladder motility can lead to serious pathology. Bitter tastants acting upon bitter taste receptors (TAS2R family) have been proposed as a novel class of smooth muscle relaxants to combat excessive contraction in the airways and other organs. To explore whether this might also emerge as an option for gallbladder diseases, we here tested bitter tastants for relaxant properties and profiled Tas2r expression in the mouse gallbladder. In organ bath experiments, the bitter tastants denatonium, quinine, dextromethorphan, and noscapine, dose-dependently relaxed the pre-contracted gallbladder. Utilizing gene-deficient mouse strains, neither transient receptor potential family member 5 (TRPM5), nor the Tas2r143/Tas2r135/Tas2r126 gene cluster, nor tuft cells proved to be required for this relaxation, indicating direct action upon smooth muscle cells (SMC). Accordingly, denatonium, quinine and dextromethorphan increased intracellular calcium concentration preferentially in isolated gallbladder SMC and, again, this effect was independent of TRPM5. RT-PCR revealed transcripts of Tas2r108, Tas2r126, Tas2r135, Tas2r137, and Tas2r143, and analysis of gallbladders from mice lacking tuft cells revealed preferential expression of Tas2r108 and Tas2r137 in tuft cells. A TAS2R143-mCherry reporter mouse labeled tuft cells in the gallbladder epithelium. An in silico analysis of a scRNA sequencing data set revealed Tas2r expression in only few cells of different identity, and from in situ hybridization histochemistry, which did not label distinct cells. Our findings demonstrate profound tuft cell- and TRPM5-independent relaxing effects of bitter tastants on gallbladder smooth muscle, but do not support the concept that these effects are mediated by bitter receptors.
Sujet(s)
Vésicule biliaire , Muscles lisses , Récepteurs couplés aux protéines G , Canaux cationiques TRPM , Animaux , Souris , Calcium/métabolisme , Dextrométhorphane/pharmacologie , Vésicule biliaire/métabolisme , Souris de lignée C57BL , Souris knockout , Relâchement musculaire/effets des médicaments et des substances chimiques , Muscles lisses/métabolisme , Myocytes du muscle lisse/métabolisme , Myocytes du muscle lisse/effets des médicaments et des substances chimiques , Noscapine/pharmacologie , Composés d'ammonium quaternaire/pharmacologie , Quinine/pharmacologie , Récepteurs couplés aux protéines G/métabolisme , Récepteurs couplés aux protéines G/génétique , Transduction du signal , Goût/physiologie , Canaux cationiques TRPM/métabolisme , Canaux cationiques TRPM/génétique , /métabolismeRÉSUMÉ
Integrin activation resulting in enhanced adhesion to the extracellular matrix plays a key role in fundamental cellular processes. Although integrin activation has been extensively studied in circulating cells such as leukocytes and platelets, much less is known about the regulation and functional impact of integrin activation in adherent cells such as smooth muscle. Here, we show that two different asthmagenic cytokines, IL-13 and IL-17A, activate type I and IL-17 cytokine receptor families, respectively, to enhance adhesion of airway smooth muscle. These cytokines also induce activation of ß1 integrins detected by the conformation-specific antibody HUTS-4. Moreover, HUTS-4 binding is increased in the smooth muscle of patients with asthma compared to nonsmokers without lung disease, suggesting a disease-relevant role for integrin activation in smooth muscle. Indeed, integrin activation induced by the ß1-activating antibody TS2/16, the divalent cation manganese, or the synthetic peptide ß1-CHAMP that forces an extended-open integrin conformation dramatically enhances force transmission in smooth muscle cells and airway rings even in the absence of cytokines. We demonstrate that cytokine-induced activation of ß1 integrins is regulated by a common pathway of NF-κB-mediated induction of RhoA and its effector Rho kinase, which in turn stimulates PIP5K1γ-mediated synthesis of PIP2 at focal adhesions, resulting in ß1 integrin activation. Taken together, these data identify a pathway by which type I and IL-17 cytokine receptor family stimulation induces functionally relevant ß1 integrin activation in adherent smooth muscle and help to explain the exaggerated force transmission that characterizes chronic airway diseases such as asthma.
Sujet(s)
Asthme , Antigènes CD29 , Interleukine-13 , Interleukine-17 , Muscles lisses , Facteur de transcription NF-kappa B , rho-Associated Kinases , Humains , Antigènes CD29/métabolisme , Interleukine-17/métabolisme , Muscles lisses/métabolisme , Facteur de transcription NF-kappa B/métabolisme , rho-Associated Kinases/métabolisme , Interleukine-13/métabolisme , Asthme/métabolisme , Transduction du signal , Adhérence cellulaire , Myocytes du muscle lisse/métabolisme , AnimauxRÉSUMÉ
Exposure to particulate matter (PM10) can induce respiratory diseases that are closely related to bronchial hyperresponsiveness. However, the involved mechanism remains to be fully elucidated. This study aimed to demonstrate the effects of PM10 on the acetylcholine muscarinic 3 receptor (CHRM3) expression and the role of the ERK1/2 pathway in rat bronchial smooth muscle. A whole-body PM10 exposure system was used to stimulate bronchial hyperresponsiveness in rats for 2 and 4 months, accompanied by MEK1/2 inhibitor U0126 injection. The whole-body plethysmography system and myography were used to detect the pulmonary and bronchoconstrictor function, respectively. The mRNA and protein levels were determined by Western blotting, qPCR, and immunofluorescence. Enzyme-linked immunosorbent assay was used to detect the inflammatory cytokines. Compared with the filtered air group, 4 months of PM10 exposure significantly increased CHRM3-mediated pulmonary function and bronchial constriction, elevated CHRM3 mRNA and protein expression levels on bronchial smooth muscle, then induced bronchial hyperreactivity. Additionally, 4 months of PM10 exposure caused an increase in ERK1/2 phosphorylation and increased the secretion of inflammatory factors in bronchoalveolar lavage fluid. Treatment with the MEK1/2 inhibitor, U0126 inhibited the PM10 exposure-induced phosphorylation of the ERK1/2 pathway, thereby reducing the PM10 exposure-induced upregulation of CHRM3 in bronchial smooth muscle and CHRM3-mediated bronchoconstriction. U0126 could rescue PM10 exposure-induced pathological changes in the bronchus. In conclusion, PM10 exposure can induce bronchial hyperresponsiveness in rats by upregulating CHRM3, and the ERK1/2 pathway may be involved in this process. These findings could reveal a potential therapeutic target for air pollution induced respiratory diseases.
Sujet(s)
Hyperréactivité bronchique , Matière particulaire , Récepteur muscarinique de type M3 , Animaux , Hyperréactivité bronchique/induit chimiquement , Hyperréactivité bronchique/physiopathologie , Hyperréactivité bronchique/métabolisme , Mâle , Matière particulaire/toxicité , Récepteur muscarinique de type M3/métabolisme , Récepteur muscarinique de type M3/génétique , Rats , Régulation positive/effets des médicaments et des substances chimiques , Bronches/effets des médicaments et des substances chimiques , Bronches/métabolisme , Bronches/anatomopathologie , Rat Sprague-Dawley , Système de signalisation des MAP kinases/effets des médicaments et des substances chimiques , Muscles lisses/effets des médicaments et des substances chimiques , Muscles lisses/métabolisme , Bronchoconstriction/effets des médicaments et des substances chimiques , Cytokines/métabolisme , Cytokines/génétique , Butadiènes , NitrilesRÉSUMÉ
Enhanced electrical activity in detrusor smooth muscle (DSM) cells is a key factor in detrusor overactivity which causes overactive bladder pathological disorders. Transient receptor potential melastatin-4 (TRPM4) channels, which are calcium-activated cation channels, play a role in regulating DSM electrical activities. These channels likely contribute to depolarizing the DSM cell membrane, leading to bladder overactivity. Our research focuses on understanding TRPM4 channel function in the DSM cells of mice, using computational modeling. We aimed to create a detailed computational model of the TRPM4 channel based on existing electrophysiological data. We employed a modified Hodgkin-Huxley model with an incorporated TRP-like current to simulate action potential firing in response to current and synaptic stimulus inputs. Validation against experimental data showed close agreement with our simulations. Our model is the first to analyze the TRPM4 channel's role in DSM electrical activity, potentially revealing insights into bladder overactivity. In conclusion, TRPM4 channels are pivotal in regulating human DSM function, and TRPM4 channel inhibitors could be promising targets for treating overactive bladder.
Sujet(s)
Simulation numérique , Canaux cationiques TRPM , Vessie hyperactive , Animaux , Humains , Souris , Potentiels d'action , Phénomènes électrophysiologiques , Muscles lisses/métabolisme , Muscles lisses/physiopathologie , Canaux cationiques TRPM/métabolisme , Vessie urinaire/métabolisme , Vessie urinaire/physiopathologie , Vessie hyperactive/métabolisme , Vessie hyperactive/physiopathologieRÉSUMÉ
Transient receptor potential vanilloid 1 (TRPV1) is a calcium-permeable ion channel that is gated by the pungent constituent of red chili pepper, capsaicin, and by related chemicals from the group of vanilloids, in addition to noxious heat. It is expressed mostly in sensory neurons to act as a detector of painful stimuli produced by pungent chemicals and high temperatures. Although TRPV1 is also found outside the sensory nervous system, its expression and function in the bladder detrusor smooth muscle (DSM) remain controversial. Here, by using Ca2+ imaging and patch clamp on isolated rat DSM cells, in addition to tensiometry on multicellular DSM strips, we show that TRPV1 is expressed functionally in only a fraction of DSM cells, in which it acts as an endoplasmic reticulum Ca2+-release channel responsible for the capsaicin-activated [Ca2+]i rise. Carbachol-stimulated contractions of multicellular DSM strips contain a TRPV1-dependent component, which is negligible in the circular DSM but reaches ≤50% in the longitudinal DSM. Activation of TRPV1 in rat DSM during muscarinic cholinergic stimulation is ensured by phospholipase A2-catalysed derivation of arachidonic acid and its conversion by lipoxygenases to eicosanoids, which act as endogenous TRPV1 agonists. Immunofluorescence detection of TRPV1 protein in bladder sections and isolated DSM cells confirmed both its preferential expression in the longitudinal DSM sublayer and its targeting to the endoplasmic reticulum. We conclude that TRPV1 is an essential contributor to the cholinergic contraction of bladder longitudinal DSM, which might be important for producing spatial and/or temporal anisotropy of bladder wall deformation in different regions during parasympathetic stimulation. KEY POINTS: The transient receptor potential vanilloid 1 (TRPV1) heat/capsaicin receptor/channel is localized in the endoplasmic reticulum membrane of detrusor smooth muscle (DSM) cells of the rat bladder, operating as a calcium-release channel. Isolated DSM cells are separated into two nearly equal groups, within which the cells either show or do not show TRPV1-dependent [Ca2+]i rise. Carbachol-stimulated, muscarinic ACh receptor-mediated contractions of multicellular DSM strips contain a TRPV1-dependent component. This component is negligible in the circular DSM but reaches ≤50% in longitudinal DSM. Activation of TRPV1 in rat DSM during cholinergic stimulation involves phospholipase A2-catalysed derivation of arachidonic acid and its conversion by lipoxygenases to eicosanoids, which act as endogenous TRPV1 agonists.
Sujet(s)
Contraction musculaire , Muscles lisses , Canaux cationiques TRPV , Vessie urinaire , Animaux , Canaux cationiques TRPV/métabolisme , Vessie urinaire/physiologie , Vessie urinaire/effets des médicaments et des substances chimiques , Vessie urinaire/métabolisme , Contraction musculaire/physiologie , Muscles lisses/physiologie , Muscles lisses/effets des médicaments et des substances chimiques , Muscles lisses/métabolisme , Rats , Mâle , Carbachol/pharmacologie , Capsaïcine/pharmacologie , Calcium/métabolisme , Rat Sprague-Dawley , Rat WistarRÉSUMÉ
G-protein-coupled receptors (GPCRs) belonging to the type 2 taste receptors (TAS2Rs) family are predominantly present in taste cells to allow the perception of bitter-tasting compounds. TAS2Rs have also been shown to be expressed in human airway smooth muscle (ASM), and TAS2R agonists relax ASM cells and bronchodilate airways despite elevating intracellular calcium. This calcium "paradox" (calcium mediates contraction by pro-contractile Gq-coupled GPCRs) and the mechanisms by which TAS2R agonists relax ASM remain poorly understood. To gain insight into pro-relaxant mechanisms effected by TAS2Rs, we employed an unbiased phosphoproteomic approach involving dual-mass spectrometry to determine differences in the phosphorylation of contractile-related proteins in ASM following the stimulation of cells with TAS2R agonists, histamine (an agonist of the Gq-coupled H1 histamine receptor) or isoproterenol (an agonist of the Gs-coupled ß2-adrenoceptor) alone or in combination. Our study identified differential phosphorylation of proteins regulating contraction, including A-kinase anchoring protein (AKAP)2, AKAP12, and RhoA guanine nucleotide exchange factor (ARHGEF)12. Subsequent signaling analyses revealed RhoA and the T853 residue on myosin light chain phosphatase (MYPT)1 as points of mechanistic divergence between TAS2R and Gs-coupled GPCR pathways. Unlike Gs-coupled receptor signaling, which inhibits histamine-induced myosin light chain (MLC)20 phosphorylation via protein kinase A (PKA)-dependent inhibition of intracellular calcium mobilization, HSP20 and ERK1/2 activity, TAS2Rs are shown to inhibit histamine-induced pMLC20 via inhibition of RhoA activity and MYPT1 phosphorylation at the T853 residue. These findings provide insight into the TAS2R signaling in ASM by defining a distinct signaling mechanism modulating inhibition of pMLC20 to relax contracted ASM.
Sujet(s)
Muscles lisses , Récepteurs couplés aux protéines G , Humains , Récepteurs couplés aux protéines G/métabolisme , Récepteurs couplés aux protéines G/agonistes , Muscles lisses/métabolisme , Muscles lisses/effets des médicaments et des substances chimiques , Phosphorylation , Relâchement musculaire/effets des médicaments et des substances chimiques , Histamine/métabolisme , Histamine/pharmacologie , Myosin-light-chain phosphatase/métabolisme , Isoprénaline/pharmacologie , Calcium/métabolisme , Protéine G RhoA/métabolisme , Goût/physiologie , Myocytes du muscle lisse/métabolisme , Myocytes du muscle lisse/effets des médicaments et des substances chimiques , Transduction du signal , Cellules cultivéesRÉSUMÉ
Gut motility undergoes a switch from myogenic to neurogenic control in late embryonic development. Here, we report on the electrical events that underlie this transition in the enteric nervous system, using the GCaMP6f reporter in neural crest cell derivatives. We found that spontaneous calcium activity is tetrodotoxin (TTX) resistant at stage E11.5, but not at E18.5. Motility at E18.5 was characterized by periodic, alternating high- and low-frequency contractions of the circular smooth muscle; this frequency modulation was inhibited by TTX. Calcium imaging at the neurogenic-motility stages E18.5-P3 showed that CaV1.2-positive neurons exhibited spontaneous calcium activity, which was inhibited by nicardipine and 2-aminoethoxydiphenyl borate (2-APB). Our protocol locally prevented muscle tone relaxation, arguing for a direct effect of nicardipine on enteric neurons, rather than indirectly by its relaxing effect on muscle. We demonstrated that the ENS was mechanosensitive from early stages on (E14.5) and that this behaviour was TTX and 2-APB resistant. We extended our results on L-type channel-dependent spontaneous activity and TTX-resistant mechanosensitivity to the adult colon. Our results shed light on the critical transition from myogenic to neurogenic motility in the developing gut, as well as on the intriguing pathways mediating electro-mechanical sensitivity in the enteric nervous system. HIGHLIGHTS: What is the central question of this study? What are the first neural electric events underlying the transition from myogenic to neurogenic motility in the developing gut, what channels do they depend on, and does the enteric nervous system already exhibit mechanosensitivity? What is the main finding and its importance? ENS calcium activity is sensitive to tetrodotoxin at stage E18.5 but not E11.5. Spontaneous electric activity at fetal and adult stages is crucially dependent on L-type calcium channels and IP3R receptors, and the enteric nervous system exhibits a tetrodotoxin-resistant mechanosensitive response. Abstract figure legend Tetrodotoxin-resistant Ca2+ rise induced by mechanical stimulation in the E18.5 mouse duodenum.
Sujet(s)
Canaux calciques de type L , Calcium , Système nerveux entérique , Motilité gastrointestinale , Neurones , Tétrodotoxine , Animaux , Canaux calciques de type L/métabolisme , Tétrodotoxine/pharmacologie , Système nerveux entérique/effets des médicaments et des substances chimiques , Système nerveux entérique/métabolisme , Système nerveux entérique/physiologie , Souris , Neurones/effets des médicaments et des substances chimiques , Neurones/métabolisme , Neurones/physiologie , Motilité gastrointestinale/effets des médicaments et des substances chimiques , Motilité gastrointestinale/physiologie , Calcium/métabolisme , Muscles lisses/effets des médicaments et des substances chimiques , Muscles lisses/métabolisme , Muscles lisses/physiologie , Souris de lignée C57BL , Inhibiteurs des canaux calciques/pharmacologie , Femelle , Contraction musculaire/effets des médicaments et des substances chimiques , Contraction musculaire/physiologie , Nicardipine/pharmacologie , Composés du boreRÉSUMÉ
Ectonucleotidases play an important role in regulating the level of extracellular nucleotides and nucleosides and are an important part of the regulation of the effects of adenosine and ATP on adenosine and P2 receptors, respectively. We have previously established the ambiguous effect of P2 receptor agonists on the contractile activity of smooth muscle tissue in rats with the valproate model of autism. In this work, HPLC was used to evaluate the activity of ectonucleotidases in the smooth muscle tissues of the internal organs of rats with a valproate model of autism. The activity of ectonucleotidases was significantly higher in the smooth muscle tissues of the duodenum, vas deferens, and bladder, but lower in the ileum and uterus. The results obtained make it possible to compare the activity of ectonucleotidases identified here with changes in P2 receptor-mediated contractility of smooth muscle tissues revealed in our previous experiments.
Sujet(s)
Trouble autistique , Contraction musculaire , Muscles lisses , Vessie urinaire , Acide valproïque , Conduit déférent , Animaux , Rats , Muscles lisses/effets des médicaments et des substances chimiques , Muscles lisses/métabolisme , Acide valproïque/pharmacologie , Trouble autistique/métabolisme , Trouble autistique/induit chimiquement , Trouble autistique/traitement médicamenteux , Mâle , Femelle , Conduit déférent/effets des médicaments et des substances chimiques , Conduit déférent/métabolisme , Vessie urinaire/effets des médicaments et des substances chimiques , Vessie urinaire/métabolisme , Vessie urinaire/enzymologie , Contraction musculaire/effets des médicaments et des substances chimiques , Utérus/effets des médicaments et des substances chimiques , Utérus/métabolisme , Iléum/effets des médicaments et des substances chimiques , Iléum/métabolisme , Iléum/enzymologie , Modèles animaux de maladie humaine , Rat Wistar , Récepteurs purinergiques P2/métabolisme , Adenosine triphosphatases/métabolismeRÉSUMÉ
6-Cyanodopamine is a novel catecholamine released from rabbit isolated heart. However, it is not known whether this catecholamine presents any biological activity. Here, it was evaluated whether 6-cyanodopamine (6-CYD) is released from rat vas deferens and its effect on this tissue contractility. Basal release of 6-CYD, 6-nitrodopamine (6-ND), 6-bromodopamine, 6-nitrodopa, and 6-nitroadrenaline from vas deferens were quantified by LC-MS/MS. Electric-field stimulation (EFS) and concentration-response curves to noradrenaline, adrenaline, and dopamine of the rat isolated epididymal vas deferens (RIEVD) were performed in the absence and presence of 6-CYD and /or 6-ND. Expression of tyrosine hydroxylase was assessed by immunohistochemistry. The rat isolated vas deferens released significant amounts of both 6-CYD and 6-ND. The voltage-gated sodium channel blocker tetrodotoxin had no effect on the release of 6-CYD, but it virtually abolished 6-ND release. 6-CYD alone exhibited a negligible RIEVD contractile activity; however, at 10 nM, 6-CYD significantly potentiated the noradrenaline- and EFS-induced RIEVD contractions, whereas at 10 and 100 nM, it also significantly potentiated the adrenaline- and dopamine-induced contractions. The potentiation of noradrenaline- and adrenaline-induced contractions by 6-CYD was unaffected by tetrodotoxin. Co-incubation of 6-CYD (100 pM) with 6-ND (10 pM) caused a significant leftward shift and increased the maximal contractile responses to noradrenaline, even in the presence of tetrodotoxin. Immunohistochemistry revealed the presence of tyrosine hydroxylase in both epithelial cell cytoplasm of the mucosae and nerve fibers of RIEVD. The identification of epithelium-derived 6-CYD and its remarkable synergism with catecholamines indicate that epithelial cells may regulate vas deferens smooth muscle contractility.
Sujet(s)
Dopamine , Contraction musculaire , Conduit déférent , Mâle , Animaux , Conduit déférent/effets des médicaments et des substances chimiques , Conduit déférent/métabolisme , Conduit déférent/physiologie , Contraction musculaire/effets des médicaments et des substances chimiques , Rats , Dopamine/métabolisme , Dopamine/pharmacologie , Rat Wistar , Norépinéphrine/pharmacologie , Norépinéphrine/métabolisme , Muscles lisses/effets des médicaments et des substances chimiques , Muscles lisses/métabolisme , Muscles lisses/physiologie , Stimulation électrique , Épinéphrine/pharmacologie , Tyrosine 3-monooxygenase/métabolismeRÉSUMÉ
In Crohn's Disease (CD), intestinal fibrosis is a prevalent yet unresolved complication arising from chronic and transmural inflammation. The histological assessment of CD intestines shows changes in tissue morphology in all the layers, including the mucosa and muscularis. This study aimed to determine the differences in fibrogenesis between mucosa and muscularis. Human precision-cut intestinal slices (hPCIS) were prepared from human intestine mucosa and muscularis and treated with TGF-ß1 and/or PDGF-BB for 72 h. Gene and protein expression and matrix metalloproteinase (MMP) activity were determined. The basal gene expression of various fibrosis markers was higher in muscularis compared to mucosa hPCIS. During incubation, Pro-Collagen-1A1 secretion increased in muscularis but not in mucosa hPCIS. MMP gene expression increased during incubation in mucosa and muscularis hPCIS, except for MMP9, MMP12, and MMP13 in muscularis hPCIS. Incubation with TGF-ß1 caused increased COL1A1 expression in the mucosa but not in muscularis hPCIS. In muscularis hPCIS, TGF-ß1 treatment caused a decrease in MMP1 and CTSK expression, while MMP13 was increased. In the presence of TGF-ß1, protease inhibitor expression was stable, except for SERPINE1, which was increased in muscularis hPCIS. We conclude that fibrogenesis is more pronounced in muscularis hPCIS compared to mucosa hPCIS, especially when stimulated with TGF-ß1.
Sujet(s)
Fibrose , Muqueuse intestinale , Facteur de croissance transformant bêta-1 , Humains , Muqueuse intestinale/métabolisme , Muqueuse intestinale/anatomopathologie , Muqueuse intestinale/effets des médicaments et des substances chimiques , Facteur de croissance transformant bêta-1/métabolisme , Chaine alpha-1 du collagène de type I , Matrix metalloproteinases/métabolisme , Matrix metalloproteinases/génétique , Maladie de Crohn/anatomopathologie , Maladie de Crohn/métabolisme , Maladie de Crohn/génétique , Collagène de type I/métabolisme , Collagène de type I/génétique , Muscles lisses/métabolisme , Muscles lisses/anatomopathologie , Muscles lisses/effets des médicaments et des substances chimiques , Mâle , Femelle , AdulteRÉSUMÉ
Fibrostenosing Crohn's disease (CD) represents a challenging clinical condition characterized by the development of symptomatic strictures within the gastrointestinal tract. Despite therapeutic advancements in managing inflammation, the progression of fibrostenotic complications remains a significant concern, often necessitating surgical intervention. Recent investigations have unveiled the pivotal role of smooth muscle cell hyperplasia in driving luminal narrowing and clinical symptomatology. Drawing parallels to analogous inflammatory conditions affecting other organs, such as the airways and blood vessels, sheds light on common underlying mechanisms of muscular hyperplasia. This review synthesizes current evidence to elucidate the mechanisms underlying smooth muscle cell proliferation in CD-associated strictures, offering insights into potential therapeutic targets. By highlighting the emerging significance of muscle thickening as a novel therapeutic target, this review aims to inform future research endeavors and clinical strategies with the goal to mitigate the burden of fibrostenotic complications in CD and other conditions.
Sujet(s)
Maladie de Crohn , Hyperplasie , Muscles lisses , Maladie de Crohn/anatomopathologie , Maladie de Crohn/complications , Humains , Hyperplasie/anatomopathologie , Sténose pathologique , Animaux , Muscles lisses/anatomopathologie , Muscles lisses/métabolisme , Fibrose , Prolifération cellulaire , Myocytes du muscle lisse/anatomopathologie , Myocytes du muscle lisse/métabolismeRÉSUMÉ
We hypothesized that teats with a teat apex score (TAS) of 4 on a 4-point scale would exhibit elevated levels of denatured collagen compared with teats with lower TAS. We procured keratin layer and smooth muscle samples from Holsteins with TAS ranging from 1 to 4, as well as from crossbred heifers (Japanese Black male and Holstein female) with TAS of 1. Teats with a TAS of 4 demonstrated increased total collagen content, higher amounts of type I collagen (the harder, thicker variant), and reduced amounts of type III collagen (the softer, thinner variant) compared with teats with lower TAS. Teats with TAS of 3 and 4 exhibited evidence of damaged collagen in smooth muscle layers compared with teats with TAS of 1. Additionally, we identified 47-kDa heat shock protein-positive fibroblasts in the smooth muscles of teats with TAS of 3 and 4. Therefore, the smooth muscle of teats with a TAS of 4 exhibited increased amounts of denatured collagen in comparison to teats with lower TAS.
Sujet(s)
Collagène , Kératines , Glandes mammaires animales , Muscles lisses , Dénaturation des protéines , Animaux , Bovins/métabolisme , Femelle , Muscles lisses/métabolisme , Collagène/métabolisme , Collagène/analyse , Kératines/métabolisme , Glandes mammaires animales/métabolisme , Mâle , Collagène de type I/métabolisme , Collagène de type I/analyse , Fibroblastes/métabolisme , Collagène de type III/métabolisme , Collagène de type III/analyseRÉSUMÉ
BACKGROUND: The natural history and pathophysiology of diverticular disease (DD) are still uncertain. An ex-vivo human complicated DD (cDD) model has recently shown a predominant transmural oxidative imbalance. The present study aims to evaluate whether the previously described alterations may precede the symptomatic form of the disease. METHODS: Colonic surgical samples obtained from patients with asymptomatic diverticulosis (DIV), complicated DD, and controls were systematically and detailed morphologically and molecularly analyzed. Therefore, histologic, histomorphometric, immunohistochemical evaluation, and gene and protein expression analysis were performed to characterize colonic muscle changes and evaluate chronic inflammation, oxidative imbalance, and hypoxia. Functional muscle activity was tested on strips and isolated cells in response to contractile and relaxant agents. KEY RESULTS: Compared with controls, DD showed a marketed increase in muscle layer thickness, smooth muscle cell syncytium disarray, and increased interstitial fibrosis; moreover, the observed features were more evident in the cDD group. These changes mainly affected longitudinal muscle and were associated with altered contraction-relaxation dynamics and fibrogenic switch of smooth muscle cells. Chronic lymphoplasmacytic inflammation was primarily evident in the mucosa and spared the muscle. A transmural increase in carbonylated and nitrated proteins, with loss of antioxidant molecules, characterized both stages of DD, suggesting early oxidative stress probably triggered by recurrent ischemic events, more pronounced in cDD, where HIF-1 was detected in both muscle and mucosa. CONCLUSION & INFERENCES: The different DD clinical scenarios are part of a progressive process, with oxidative imbalance representing a new target in the management of DD.
Sujet(s)
Évolution de la maladie , Muscles lisses , Stress oxydatif , Humains , Mâle , Femelle , Adulte d'âge moyen , Sujet âgé , Stress oxydatif/physiologie , Muscles lisses/métabolisme , Muscles lisses/anatomopathologie , Maladies diverticulaires/métabolisme , Diverticulose colique/métabolisme , Diverticulose colique/anatomopathologie , Côlon/anatomopathologie , Côlon/métabolisme , Contraction musculaire/physiologieRÉSUMÉ
The influence of accelerated electrons on neuronal structures is scarcely explored compared to gamma and X-rays. This study aims to investigate the effects of accelerated electron radiation on some pivotal neurotransmitter circuits (cholinergic and serotonergic) of rats' myenteric plexus. Male Wistar rats were irradiated with an electron beam (9 MeV, 5 Gy) generated by a multimodality linear accelerator. The contractile activity of isolated smooth muscle samples from the gastric corpus was measured. Furthermore, an electrical stimulation (200 µs, 20 Hz, 50 s, 60 V) was performed on the samples and an assessment of the cholinergic and serotonergic circuits was made. Five days after irradiation, the recorded mechanical responses were biphasic-contraction/relaxation in controls and contraction/contraction in irradiated samples. The nature of the contractile phase of control samples was cholinergic with serotonin involvement. The relaxation phase involved ACh-induced nitric oxide release from gastric neurons. There was a significant increase in serotonergic involvement during the first and second contractile phases of the irradiated samples, along with a diminished role of acetylcholine in the first phase. This study demonstrates an increased involvement of serotonergic neurotransmitter circuits in the gastric myenteric plexus caused by radiation with accelerated electrons.
Sujet(s)
Électrons , Plexus myentérique , Rat Wistar , Estomac , Animaux , Plexus myentérique/effets des radiations , Plexus myentérique/métabolisme , Mâle , Rats , Estomac/innervation , Estomac/effets des radiations , Estomac/physiologie , Muscles lisses/physiologie , Muscles lisses/effets des radiations , Muscles lisses/métabolisme , Sérotonine/métabolisme , Contraction musculaire/effets des radiations , Contraction musculaire/physiologie , Acétylcholine/métabolisme , Monoxyde d'azote/métabolismeRÉSUMÉ
Mitochondria play a crucial role in maintaining Ca2+ homeostasis in cells. Due to the critical regulatory role of the products of oxidative and non-oxidative metabolism of L-arginine, it is essential to clarify their effect on Ca2+ transport in smooth muscle mitochondria. Experiments were performed on the uterine myocytes of rats and isolated mitochondria. The possibility of NO synthesis by mitochondria was demonstrated by confocal microscopy and spectrofluorimetry methods using the NO-sensitive fluorescent probe DAF-FM and Mitotracker Orange CM-H2TMRos. It was shown that 50 µM L-arginine stimulates the energy-dependent accumulation of Ca2+ in mitochondria using the fluorescent probe Fluo-4 AM. A similar effect occurred when using nitric oxide donors 100 µM SNP, SNAP, and sodium nitrite (SN) directly. The stimulating effect was eliminated in the presence of the NO scavenger C-PTIO. Nitric oxide reduces the electrical potential in mitochondria without causing them to swell. The stimulatory effect of spermine on the accumulation of Ca2+ by mitochondria is attributed to the enhancement of NO synthesis, which was demonstrated with the use of C-PTIO, NO-synthase inhibitors (100 µM NA and L-NAME), as well as by direct monitoring of NO synthesis fluorescent probe DAF-FM. A conclusion was drawn about the potential regulatory effect of the product of the oxidative metabolism of L-arginine - NO on the transport of Ca2+ in the mitochondria of the myometrium, as well as the corresponding effect of the product of non-oxidative metabolism -spermine by increasing the synthesis of NO in these subcellular structures.
Sujet(s)
Arginine , Calcium , Monoxyde d'azote , Femelle , Animaux , Arginine/métabolisme , Calcium/métabolisme , Rats , Monoxyde d'azote/métabolisme , Oxydoréduction , Myomètre/métabolisme , Myomètre/effets des médicaments et des substances chimiques , Mitochondries du muscle/métabolisme , Mitochondries du muscle/effets des médicaments et des substances chimiques , Rat Wistar , Mitochondries/métabolisme , Mitochondries/effets des médicaments et des substances chimiques , Utérus/métabolisme , Utérus/effets des médicaments et des substances chimiques , Spermine/métabolisme , Spermine/pharmacologie , Donneur d'oxyde nitrique/pharmacologie , Donneur d'oxyde nitrique/métabolisme , Muscles lisses/métabolisme , Muscles lisses/effets des médicaments et des substances chimiques , Transport biologique/effets des médicaments et des substances chimiquesRÉSUMÉ
BACKGROUND: Low-intensity pulsed ultrasound (LIPUS) combined with acupoint can promote gastric motility of diabetic rats. The switch of gastric smooth muscle cell (GSMCs) phenotype was related to the diabetes-induced gastric dysfunction, but the mechanism is not clearly elucidated. This study was aimed at exploring the underlying mechanism of LIPUS stimulation application in diabetic gastroparesis rats. METHODS: In this study, Sprague-Dawley male rats were divided into three groups: control group (CON), diabetic gastroparesis group (DGP), and LIPUS-treated group (LIPUS). LIPUS irradiation was performed bilaterally at ST36 for 20 min per day for 4 weeks. The gastric emptying rate was measured by ultrasound examination. Contraction ability of GSMCs was assessed by muscle strip experiment. The expression of related proteins or mRNAs including α-SMA, SM22α, MHC, RhoA, Rock2, p-MYPT1, MYPT1, p-MLC, MLC, MALAT1, miR-449a, and DLL1 was detected by different methods such as western blotting, RT-qPCR, immunohistochemistry, and immunofluorescence staining, as appropriate. KEY RESULTS: (a) LIPUS stimulation at ST36 could improve the gastric motility dysfunction of diabetic rats. (b) LIPUS increased RhoA, Rock2, p-MYPT1, and p-MLC expression level. (c) MALAT1 and DLL1 contents were decreased, but the level of miR-449a was increased in the LIPUS group. CONCLUSIONS & INFERENCES: LIPUS may affect the contractile marker expression of gastric smooth muscle through the RhoA/Rock and MALAT1/miR-449a/DLL1 pathway to ameliorate DGP.
Sujet(s)
Points d'acupuncture , Diabète expérimental , microARN , Contraction musculaire , Muscles lisses , ARN long non codant , Rat Sprague-Dawley , Transduction du signal , Animaux , Mâle , Rats , microARN/métabolisme , microARN/génétique , Muscles lisses/métabolisme , ARN long non codant/métabolisme , ARN long non codant/génétique , Diabète expérimental/métabolisme , rho-Associated Kinases/métabolisme , rho-Associated Kinases/génétique , Gastroparésie/métabolisme , Gastroparésie/thérapie , Ondes ultrasonores , Protéine G RhoA/métabolisme , Protéines membranaires/métabolisme , Protéines membranaires/génétique , Estomac , Vidange gastrique/physiologie , Ultrasonothérapie/méthodes , Myocytes du muscle lisse/métabolisme , Protéines G rhoRÉSUMÉ
Multidrug resistance proteins type 4 (MRP4) and 5 (MRP5) play pivotal roles in the transport of cyclic nucleotides in various tissues. However, their specific functions within the lower urinary tract remain relatively unexplored. This study aimed to investigate the effect of pharmacological inhibition of MRPs on cyclic nucleotide signaling in isolated pig bladder. The relaxation responses of the bladder were assessed in the presence of the MRP inhibitor, MK571. The temporal changes in intra- and extracellular levels of cAMP and cGMP in stimulated tissues were determined by mass spectrometry. The gene (ABCC4) and protein (MRP4) expression were also determined. MK571 administration resulted in a modest relaxation effect of approximately 26% in carbachol-precontracted bladders. The relaxation induced by phosphodiesterase inhibitors such as cilostazol, tadalafil, and sildenafil was significantly potentiated in the presence of MK571. In contrast, no significant potentiation was observed in the relaxation induced by substances elevating cAMP levels or stimulators of soluble guanylate cyclase. Following forskolin stimulation, both intracellular and extracellular cAMP concentrations increased by approximately 15.8-fold and 12-fold, respectively. Similarly, stimulation with tadalafil + BAY 41-2272 resulted in roughly 8.2-fold and 3.4-fold increases in intracellular and extracellular cGMP concentrations, respectively. The presence of MK571 reduced only the extracellular levels of cGMP. This study reveals the presence and function of MRP4 transporters within the porcine bladder and paves the way for future research exploring the role of this transporter in both underactive and overactive bladder disorders.NEW & NOTEWORTHY This study investigates the impact of pharmacological inhibition of MRP4 and MRP5 transporters on cyclic nucleotide signaling in isolated pig bladders. MK571 administration led to modest relaxation, with enhanced effects observed in the presence of phosphodiesterase inhibitors. However, substances elevating cAMP levels remained unaffected. MK571 selectively reduced extracellular cGMP levels. These findings shed light on the role of MRP4 transporters in the porcine bladder, opening avenues for further research into bladder disorders.
Sujet(s)
GMP cyclique , Protéines associées à la multirésistance aux médicaments , Vessie urinaire , Animaux , Vessie urinaire/métabolisme , Vessie urinaire/effets des médicaments et des substances chimiques , Protéines associées à la multirésistance aux médicaments/métabolisme , Protéines associées à la multirésistance aux médicaments/génétique , GMP cyclique/métabolisme , Suidae , Quinoléines/pharmacologie , AMP cyclique/métabolisme , Relâchement musculaire/effets des médicaments et des substances chimiques , Mâle , Muscles lisses/effets des médicaments et des substances chimiques , Muscles lisses/métabolisme , Femelle , Transduction du signal , Inhibiteurs de la phosphodiestérase/pharmacologie , PropionatesRÉSUMÉ
Visceral myopathy is a life-threatening disease characterized by muscle weakness in the bowel, bladder, and uterus. Mutations in smooth muscle γ-actin (ACTG2) are the most common cause of the disease, but the mechanisms by which the mutations alter muscle function are unknown. Here, we examined four prevalent ACTG2 mutations (R40C, R148C, R178C, and R257C) that cause different disease severity and are spread throughout the actin fold. R178C displayed premature degradation, R148C disrupted interactions with actin-binding proteins, R40C inhibited polymerization, and R257C destabilized filaments. Because these mutations are heterozygous, we also analyzed 50/50 mixtures with wild-type (WT) ACTG2. The WT/R40C mixture impaired filament nucleation by leiomodin 1, and WT/R257C produced filaments that were easily fragmented by smooth muscle myosin. Smooth muscle tropomyosin isoform Tpm1.4 partially rescued the defects of R40C and R257C. Cryo-electron microscopy structures of filaments formed by R40C and R257C revealed disrupted intersubunit contacts. The biochemical and structural properties of the mutants correlate with their genotype-specific disease severity.
Sujet(s)
Actines , Mutation faux-sens , Humains , Actines/métabolisme , Actines/génétique , Pseudo-obstruction intestinale/génétique , Pseudo-obstruction intestinale/métabolisme , Pseudo-obstruction intestinale/anatomopathologie , Cryomicroscopie électronique , Muscles lisses/métabolisme , Muscles lisses/anatomopathologie , Modèles moléculaires , Liaison aux protéinesRÉSUMÉ
The transitional epithelial cells (urothelium) that line the lumen of the urinary bladder form a barrier between potentially harmful pathogens, toxins, and other bladder contents and the inner layers of the bladder wall. The urothelium, however, is not simply a passive barrier, as it can produce signaling factors, such as ATP, nitric oxide, prostaglandins, and other prostanoids, that can modulate bladder function. We investigated whether substances produced by the urothelium could directly modulate the contractility of the underlying urinary bladder smooth muscle. Force was measured in isolated strips of mouse urinary bladder with the urothelium intact or denuded. Bladder strips developed spontaneous tone and phasic contractions. In urothelium-intact strips, basal tone, as well as the frequency and amplitude of phasic contractions, were 25%, 32%, and 338% higher than in urothelium-denuded strips, respectively. Basal tone and phasic contractility in urothelium-intact bladder strips were abolished by the cyclooxygenase (COX) inhibitor indomethacin (10 µM) or the voltage-dependent Ca2+ channel blocker diltiazem (50 µM), whereas blocking neuronal sodium channels with tetrodotoxin (1 µM) had no effect. These results suggest that prostanoids produced in the urothelium enhance smooth muscle tone and phasic contractions by activating voltage-dependent Ca2+ channels in the underlying bladder smooth muscle. We went on to demonstrate that blocking COX inhibits the generation of transient pressure events in isolated pressurized bladders and greatly attenuates the afferent nerve activity during bladder filling, suggesting that urothelial prostanoids may also play a role in sensory nerve signaling.NEW & NOTEWORTHY This paper provides evidence for the role of urothelial-derived prostanoids in maintaining tone in the urinary bladder during bladder filling, not only underscoring the role of the urothelium as more than a barrier but also contributing to active regulation of the urinary bladder. Furthermore, cyclooxygenase products greatly augment sensory nerve activity generated by bladder afferents during bladder filling and thus may play a role in perception of bladder fullness.